Cargando…
Effectiveness of statins in chronic kidney disease
Background: Previous studies show that statins reduce total cholesterol (TC) concentration by both 21% in primary prevention (PP) and secondary prevention (SP) in clinical trials and by ∼24% in the general population. There are few data about the efficacy of statins on TC concentration and cardiovas...
Autores principales: | Sheng, X., Murphy, M.J., MacDonald, T.M., Wei, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381221/ https://www.ncbi.nlm.nih.gov/pubmed/22383690 http://dx.doi.org/10.1093/qjmed/hcs031 |
Ejemplares similares
-
The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population
por: Sheng, Xia, et al.
Publicado: (2012) -
‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
por: Murphy, Michael J, et al.
Publicado: (2008) -
Effects of statin treatment in patients with coronary artery disease and chronic kidney disease
por: Kaneko, Hidehiro, et al.
Publicado: (2013) -
Effects of Statin Use in Advanced Chronic Kidney Disease Patients
por: Huang, Tao-Min, et al.
Publicado: (2018) -
Effect of Statins on Renal Function in Chronic Kidney Disease Patients
por: Hu, Ping-Jen, et al.
Publicado: (2018)